Santander Bank Polska (SPL:ASX) Investor Relations Material

Overview

Starpharma Holdings Limited is an Australian company that specializes in the research, development, and commercialization of dendrimer products for various applications, especially in the pharmaceutical and life sciences industries. The company's main focus is on VivaGel, a microbicidal agent that is currently undergoing Phase III clinical trials for the prevention and management of bacterial vaginosis. The product also has potential as a condom coating for the prevention of sexually transmitted infections.

Frequently Asked Questions

What is Santander Bank Polska's ticker?

Santander Bank Polska's ticker is SPL

What exchange is Santander Bank Polska traded on?

The company's shares trade on the ASX stock exchange

Where are Santander Bank Polska's headquarters?

They are based in Abbotsford, Victoria

How many employees does Santander Bank Polska have?

There are 11-50 employees working at Santander Bank Polska

What is Santander Bank Polska's website?

It is santander.pl/en/investor-relations/about-company

What type of sector is Santander Bank Polska?

Santander Bank Polska is in the Healthcare sector

What type of industry is Santander Bank Polska?

Santander Bank Polska is in the Biotechnology industry

Who are Santander Bank Polska's peers and competitors?

The following five companies are Santander Bank Polska's industry peers:

- Circor International Inc

- Medicenna Therapeutics

- CASI Pharmaceuticals Inc

- Axsome Therapeutics

- PTC Therapeutics